AI startups

Y Combinator’s founder matching tool has quietly become one of most powerful offerings. That’s how medical records AI startup Hona was founded.

Despite an overall decline in startup investing, funding for AI surged in the past year. Capital toward generative AI ventures alone nearly octupled from 2022 to 2023, reaching $25.2 billion…

Despite all the enthusiasm, there’s a niggling detail that deserves our attention: AI startups often have worse economics than most software startups.

A European Union plan to support homegrown AI startups by providing them with access to processing power for model training on the bloc’s supercomputers, which was announced back in September…

We’re seeing a lot of folks push their capital into just a few squares on the betting table. One way or another, the result is going to be notable.

When you take venture capital money, investors will shape everything from your strategy and product to your thought process. That may not be best for what you’re offering, especially in…

Here’s what these 15 investors would have done differently in 2023 if they had a crystal ball to divine the future.

When Bret Taylor announced he was stepping down as co-CEO and co-chair at Salesforce in November, it was easy to be cynical about him saying he wanted to go build…

As AI teams bring new products to life, it’s critical that they ask themselves the right questions to eliminate all kinds of bias.

Six investors we surveyed recently told us that the macro environment has had a big impact on deal flow, valuations and M&A in biotech.

To get a better idea of how AI is affecting biotech in 2022, we asked six investors to tell us what they look for in a biotech startup today.

If your deck doesn’t give prospective investors a clear idea of how you will put their money to work, you’re not going home with a term sheet.

Valuing startups is an established process today, but do the methods employed apply equally to pre-revenue companies using novel AI?